Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0019829 (Hodgkin's disease)
 30,247 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A large amount of information regarding the kinetics of biochemical reactions involved in visual transduction was derived from electrophysiological studies on dark-adapted rod outer segments. Hodgkin et al. [(1985) J. Physiol. 358, 447-468] observed that when Na was replaced with Li in the perfusion solution bathing the rod outer segment, the dark current slowly declined to zero. This decline was thought to result from a rise in intracellular calcium which was hypothesized to inhibit guanylate cyclase activity and reduce the cyclic GMP concentration. Rod outer segments contain membrane and soluble guanylate cyclase activities, and we show here that Li directly inhibits both types of activities very strongly. Both the basal (at high calcium) and the stimulated (at low calcium) activities of the membrane enzyme were inhibited by Li. Half-maximal inhibition of the stimulated enzyme was at 30 mM Li while for the basal activity it was at 100 mM. Over 80% of the activated enzyme was inhibited at 110 mM Li. The soluble guanylate cyclase activity was stimulated by nitroprusside. One hundred millimolar Li inhibited the basal activity by 20-30%, but the inhibition of the nitroprusside-stimulated (soluble) enzyme was much stronger, resembling that of the activated membrane enzyme. Half-maximal inhibition occurred at 30 mM, and about 80% inhibition was found at 100 mM Li. Stimulation of the soluble enzyme by nitroprusside was independent of calcium in the physiological range. The inhibition of the stimulated enzyme by Li was similarly independent of calcium, except at unphysiologically high concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Effects of lithium on basal and modulated activities of the particulate and soluble guanylate cyclases in retinal rod outer segments. 135 98

Learning and memory are critically dependent on basal forebrain cholinergic (BFC) neuron excitability, which is modulated profoundly by leak K(+) channels. Many neuromodulators closing leak K(+) channels have been reported, whereas their endogenous opener remained unknown. We here demonstrate that nitric oxide (NO) can be the endogenous opener of leak K(+) channels in the presumed BFC neurons. Bath application of 1 mM S-nitroso-N-acetylpenicillamine (SNAP), an NO donor, induced a long-lasting hyperpolarization, which was often interrupted by a transient depolarization. Soluble guanylyl cyclase inhibitors prevented SNAP from inducing hyperpolarization but allowed SNAP to cause depolarization, whereas bath application of 0.2 mM 8-bromoguanosine-3',5'-cyclomonophosphate (8-Br-cGMP) induced a similar long-lasting hyperpolarization alone. These observations indicate that the SNAP-induced hyperpolarization and depolarization are mediated by the cGMP-dependent and -independent processes, respectively. When examined with the ramp command pulse applied at -70 mV under the voltage-clamp condition, 8-Br-cGMP application induced the outward current that reversed at K(+) equilibrium potential (E(K)) and displayed Goldman-Hodgkin-Katz rectification, indicating the involvement of voltage-independent K(+) current. By contrast, SNAP application in the presumed BFC neurons either dialyzed with the GTP-free internal solution or in the presence of 10 muM Rp-8-bromo-beta-phenyl-1,N(2)-ethenoguanosine 3',5'-cyclic monophosphorothioate sodium salt, a protein kinase G (PKG) inhibitor, induced the inward current that reversed at potentials much more negative than E(K) and close to the reversal potential of Na(+)-K(+) pump current. These observations strongly suggest that NO activates leak K(+) channels through cGMP-PKG-dependent pathway to markedly decrease the excitability in BFC neurons, while NO simultaneously causes depolarization by the inhibition of Na(+)-K(+) pump through ATP depletion.
 ...
PMID:Nitric oxide activates leak K+ currents in the presumed cholinergic neuron of basal forebrain. 1792 63